Disclosures
This manuscript has been published in a journal supplement that was created with an unrestricted educational grant from Gilead Portugal. Ben de Pauw has received speaker bureau honoraria from Pfizer (annually), Gilead and Merck, and has received remittance advice from Astellas and Basilea Pharma.
Rights and permissions
About this article
Cite this article
Contemplations on the Challenge of Invasive Fungal Disease. Clin Drug Investig 33 (Suppl 1), 57–58 (2013). https://doi.org/10.1007/s40261-012-0024-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40261-012-0024-2